Related Experiment Video
Updated: Dec 10, 2025

13:39
Optical Trapping of Nanoparticles
Published on: January 15, 2013
22.8K
Exploring optical spectroscopic techniques and nanomaterials for virus detection
Sello Lebohang Manoto1, Ahmed El-Hussein2, Rudzani Malabi1
1Council for Scientific and Industrial Research (CSIR), National Laser Centre, P.O. Box 395, Pretoria 0001, South Africa.
Saudi Journal of Biological Sciences
|September 2, 2020
Summary
This study developed a novel biosensor for detecting human immunodeficiency virus (HIV). The biosensor uses specific antibodies and nanoparticles to capture and identify HIV pseudoviruses, showing promise for point-of-care diagnostics.
Area of Science:
- Biotechnology
- Nanotechnology
- Immunology
Background:
- Viral infections, including COVID-19 and HIV, present global health challenges, highlighting limitations in current diagnostic capabilities.
- The development of affordable, portable, and sensitive point-of-care (POC) biosensors for HIV detection is crucial for effective clinical decision-making.
Purpose of the Study:
- To present a proof-of-concept for a novel biosensor system designed for the detection of human immunodeficiency virus type 1 (HIV-1) pseudoviruses.
- To utilize anti-HIV1 gp41 antibodies as capturing agents immobilized on glass substrates for HIV detection.
Main Methods:
- Immobilization of anti-HIV1 gp41 antibodies onto silane-treated glass substrates.
- Detection of HIV pseudoviruses using antibody-conjugated selenium nanoparticles (SeNPs) and gold nanoclusters (AuNCs).
- Characterization of nanoparticle conjugation and surface morphology using UV-vis spectroscopy, TEM, zeta potential, fluorescence microscopy, AFM, and Raman spectroscopy.
Main Results:
- Successful conjugation of SeNPs and AuNCs to anti-HIV1 gp41 antibodies was confirmed by UV-vis and zeta potential analyses.
- Antibody-immobilized substrates effectively captured intact HIV pseudoviruses, as evidenced by fluorescence microscopy and AFM.
- Raman spectroscopy confirmed the presence of HIV-related biomolecules, differentiating between substrates with and without pseudoviruses.
Conclusions:
- The developed biosensor system demonstrates significant potential for sensitive and accurate HIV detection.
- This proof-of-concept provides a foundation for developing advanced point-of-care biosensors for HIV diagnosis.

